je.st
news
Allergan near buyout of up to $65 billion to escape Valeant, Ackman: source
2014-11-17 03:24:15| Biotech - Topix.net
Allergan Inc is close to a buyout deal worth up to $65.5 billion by Actavis Plc, one that could end months of pursuit by Canada's Valeant Pharmaceuticals and William Ackman's hedge fund, Pershing Square Capital Management, according to a person familiar with the matter. Actavis may pay Allergan between $215 and $220 per share, with the final price likely coming at the high end of that range, according to the source.
Tags: source
escape
billion
buyout
Category:Biotechnology and Pharmaceuticals